Overview
- 22 inspections across 22 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-11-15.
At a glance
Inspections
22
Sites
22
Observations
0
Career since
Feb 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cosette Pharmaceuticals, Inc. | 15 Nov 2024 | Human Drugs | |
| Amneal Pharmaceuticals Private Limited | 19 Jul 2024 | Human Drugs | |
| Intas Pharmaceuticals Limited | 12 Jul 2024 | Human Drugs | |
| Novum Pharmaceutical Research Services Inc. | 12 May 2017 | Human Drugs | |
| Amgen, Inc. | 17 Feb 2017 | Human Drugs | On file |
Sites inspected
Cosette Pharmaceuticals, Inc.South Plainfield, United States1 insp.
Amneal Pharmaceuticals Private LimitedMatoda, India1 insp.
Intas Pharmaceuticals LimitedAhmedabad, India1 insp.
Novum Pharmaceutical Research Services Inc.Scarborough, Canada1 insp.
Amgen, Inc.Thousand Oaks, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Li-Hong P Yeh3 shared
Ruben C Ayala3 shared
Li-Hong Yeh3 shared
Melkamu Getie Kebtie3 shared
Arindam Dasgupta2 shared
Young M Choi2 shared
Mohsen Rajabi Abhari2 shared
Gajendiran Mahadevan2 shared
Stanley Au1 shared
Gopa Biswas1 shared
Full investigator report
Get the verbatim findings behind Nicola M Fenty-Stewart's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site